Rchr
J-GLOBAL ID:201401097407575239   Update date: Oct. 24, 2024

Ishimori Takayoshi

イシモリ タカヨシ | Ishimori Takayoshi
Affiliation and department:
Research field  (1): Radiology
Research theme for competitive and other funds  (4):
  • 2021 - 2026 Assessment of the relationship between the dynamics of tumor hypoxia areas and hypoxia inducible factor in radiotherapy for pancreatic cancer
  • 2020 - 2023 Exploration of Companion Diagnosis and Personalized Medicine of Tumor Using Chemokine Receptor Imaging
  • 2020 - 2023 89Zr-トラスツズマブとPET/MRおよび乳房専用PET装置を用いた画像診断
  • 2018 - 2021 Integration of the dynamics of tumor hypoxia and high-precision radiotherapy for refractory cancer
Papers (192):
  • Kazuya Ohtsuki, Masahiro Sawada, Wataru Yoshizaki, Takayoshi Ishimori, Nobukatsu Sawamoto, Yasutaka Fushimi, Hiroki Toda. Quantitative susceptibility mapping and a nonlinearly transformed atlas for targeting the ventral intermediate nucleus of the thalamus in a patient with tremor and thalamic hypertrophy: illustrative case. Journal of neurosurgery. Case lessons. 2024. 7. 14
  • Shunsuke Yuge, Kanae K. Miyake, Takayoshi Ishimori, Masako Kataoka, Yoshiaki Matsumoto, Masae Torii, Masahiro Yakami, Hiroyoshi Isoda, Kyoko Takakura, Satoshi Morita, et al. Performance of dedicated breast PET in breast cancer screening: comparison with digital mammography plus digital breast tomosynthesis and ultrasound. Annals of Nuclear Medicine. 2023
  • Yang Wang, Yasutaka Fushimi, Yoshiki Arakawa, Yoichi Shimizu, Kohei Sano, Akihiko Sakata, Satoshi Nakajima, Sachi Okuchi, Takuya Hinoda, Sonoko Oshima, et al. Evaluation of isocitrate dehydrogenase mutation in 2021 world health organization classification grade 3 and 4 glioma adult-type diffuse gliomas with 18F-fluoromisonidazole PET. Japanese journal of radiology. 2023
  • 三宅 可奈江, 高田 正泰, 志水 陽一, 弓削 瞬介, 北野 香雪, 石守 崇好, 片岡 正子, 板垣 孝治, 川島 雅央, 戸井 雅和, et al. De novo ER陽性乳癌における[F-18]-FES PETの診断能 全身PET/CTと乳房PET/MRの比較. 核医学. 2023. 60. Suppl. S184-S184
  • Aika Okazawa, Mami Iima, Masako Kataoka, Ryosuke Okumura, Sachiko Takahara, Tomotaka Noda, Taro Nishi, Takayoshi Ishimori, Yuji Nakamoto. Diagnostic Utility of an Adjusted DWI Lexicon Using Multiple b-values to Evaluate Breast Lesions in Combination with BI-RADS. Magnetic Resonance in Medical Sciences. 2023
more...
MISC (79):
  • 弓削瞬介, 三宅可奈江, 高田正泰, 志水陽一, 北野香雪, 片岡正子, 石守崇好, 川島雅央, 河口浩介, 戸井雅和, et al. 浸潤性小葉癌におけるF-18FES PETの有用性. 核医学(Web). 2023. 60. Supplement
  • 三宅可奈江, 高田正泰, 志水陽一, 弓削瞬介, 北野香雪, 石守崇好, 片岡正子, 板垣孝治, 川島雅央, 戸井雅和, et al. De novo ER陽性乳癌における[F-18]-FES PETの診断能:全身PET/CTと乳房PET/MRの比較. 核医学(Web). 2023. 60. Supplement
  • 弓削瞬介, 三宅可奈江, 片岡正子, 八上全弘, 磯田裕義, 石守崇好, 松本純明, 高田正泰, 戸井雅和, 中本裕士. 任意型検診における乳房専用PETの診断能-初診群と再診群による比較-. 核医学(Web). 2022. 59. Supplement
  • Tomoaki Otani, Takayoshi Ishimori, Yoichi Shimizu, Tsuneo Saga, Yuji Nakamoto. Detection efficacy of PSMA-targeted PET/CT with F-18-FSU880 in patients with biochemical recurrence of prostate cancer. JOURNAL OF NUCLEAR MEDICINE. 2021. 62
  • Kanae Miyake, Takayoshi Ishimori, Masako Kataoka, Shunsuke Yuge, Tsuneo Saga, Masakazu Toi, Yuji Nakamoto. Subcutaneous or cutaneous F-18-FDG uptake in the breast co-existing with breast cancer. JOURNAL OF NUCLEAR MEDICINE. 2021. 62
more...
Books (1):
  • Radiological Evaluation of Response and Resistance of Ibritumomab. Resistance to Ibritumomab in Lymphoma.
    Springer 2018
Lectures and oral presentations  (1):
  • [F-18] FDG-PET/CT of Lung Cancer
    (Annual Meeting of Society of Nuclear Medicine and Molecular Imaging 2016)
Work history (1):
  • Kyoto University
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page